We use cookies so that we can improve the experience for visitors to our websites. This includes cookies that are necessary for the operation of our websites, as well as other cookies used for analytics purposes. We will not use analytical cookies unless you enable them.
For more information about our use of cookies, please refer to our cookie policy.
These cookies allow us to understand how our websites are used, and to improve our websites over time.
Enable analytics cookies:
Save and close
Indivior is working to change patients' lives by developing medicines to treat substance use disorders and serious mental illnesses.
Learn more about the steps we are taking to minimize our environmental impact, reach our goals for diversity and inclusion and lead on social impact through our mission to help patients.
January 20 2023
Indivior to Announce Q4 / FY 2022 Results and Host Webcast on February 16th
December 7 2022
Indivior 2022 Capital Markets Day
Accelerate your career by making a difference
Driving development in addressing addiction and behavioural health issues
The latest information on Indivior